Structure‐Activity Analyses of β‐Amyloid Peptides: Contributions of the β25–35 Region to Aggregation and Neurotoxicity
暂无分享,去创建一个
C. Cotman | C. Pike | C. Glabe | D. Cribbs | Christian J. Pike | Carl W. Cotman | Andrea J. Walencewicz‐Wasserman | Joseph Kosmoski | David H. Cribbs | Charles G. Glabe | A. J. Walencewicz-Wasserman | J. Kosmoski
[1] M. Mattson,et al. β-Amyloid precursor protein and alzheimer's disease: The peptide plot thickens , 1992, Neurobiology of Aging.
[2] D. Kirschner,et al. Neurotrophic and neurotoxic effects of amyloid beta protein: reversal by tachykinin neuropeptides. , 1990, Science.
[3] J. Ghiso,et al. In vitro formation of amyloid fibrils from two synthetic peptides of different lengths homologous to Alzheimer's disease β-protein , 1986 .
[4] Carl W. Cotman,et al. In vitro aging of ß-amyloid protein causes peptide aggregation and neurotoxicity , 1991, Brain Research.
[5] L. Thal,et al. Solvent effects on beta protein toxicity in vivo , 1992, Neurobiology of Aging.
[6] M. Mattson,et al. Calcium-destabilizing and neurodegenerative effects of aggregated β-amyloid peptide are attenuated by basic FGF , 1993, Brain Research.
[7] Synthetic peptide homologous to beta protein from Alzheimer disease forms amyloid-like fibrils in vitro. , 1987, Proceedings of the National Academy of Sciences of the United States of America.
[8] M. Beal,et al. An in vivo model for the neurodegenerative effects of beta amyloid and protection by substance P. , 1991, Proceedings of the National Academy of Sciences of the United States of America.
[9] Brian J Cummings,et al. beta-Amyloid induces neuritic dystrophy in vitro: similarities with Alzheimer pathology. , 1992, Neuroreport.
[10] D. K. Rush,et al. Intracerebral /sB-amyloid(25–35) produces tissue damage: Is it neurotoxic? , 1992, Neurobiology of Aging.
[11] H. Levine,et al. Thioflavine T interaction with synthetic Alzheimer's disease β‐amyloid peptides: Detection of amyloid aggregation in solution , 1993, Protein science : a publication of the Protein Society.
[12] G. Glenner,et al. Amyloid fibrils formed from a segment of the pancreatic islet amyloid protein. , 1988, Biochemical and biophysical research communications.
[13] Regina M. Murphy,et al. Kinetics of aggregation of synthetic β-amyloid peptide , 1992 .
[14] H. Schägger,et al. Tricine-sodium dodecyl sulfate-polyacrylamide gel electrophoresis for the separation of proteins in the range from 1 to 100 kDa. , 1987, Analytical biochemistry.
[15] C. Cotman,et al. Assembly and aggregation properties of synthetic Alzheimer's A4/beta amyloid peptide analogs. , 1992, The Journal of biological chemistry.
[16] G. Forloni,et al. Neurotoxicity of a prion protein fragment , 1993, Nature.
[17] Carl W. Cotman,et al. Neurodegeneration induced by beta-amyloid peptides in vitro: the role of peptide assembly state , 1993, The Journal of neuroscience : the official journal of the Society for Neuroscience.
[18] P. Lansbury,et al. Molecular determinants of amyloid deposition in Alzheimer's disease: conformational studies of synthetic beta-protein fragments. , 1990, Biochemistry.
[19] P. Fraser,et al. Effects of Sulfate Ions on Alzheimer β/A4 Peptide Assemblies: Implications for Amyloid Fibril‐Proteoglycan Interactions , 1992, Journal of neurochemistry.
[20] C. Maggi,et al. Interaction of amyloid β protein (25–35) with tachykinin receptors , 1992, Neuropeptides.
[21] C. Geula,et al. The acute neurotoxicity and effects upon cholinergic axons of intracerebrally injected β-amyloid in the rat brain , 1992, Neurobiology of Aging.
[22] R G Griffin,et al. An unusual peptide conformation may precipitate amyloid formation in Alzheimer's disease: application of solid-state NMR to the determination of protein secondary structure. , 1991, Biochemistry.
[23] P. Fraser,et al. Morphology and antibody recognition of synthetic β‐amyloid peptides , 1991 .
[24] G. Fasman,et al. Computed circular dichroism spectra for the evaluation of protein conformation. , 1969, Biochemistry.
[25] M. Mitsuhashi,et al. Amyloid beta protein substituent peptides do not interact with the substance P receptor expressed in cultured cells. , 1991, Brain research. Molecular brain research.
[26] C. Barrow,et al. Solution structures of beta peptide and its constituent fragments: relation to amyloid deposition. , 1991, Science.
[27] J. Hardy,et al. Early-onset Alzheimer's disease caused by mutations at codon 717 of the β-amyloid precursor protein gene , 1991, Nature.
[28] A. D. Hershey,et al. Amyloid-beta peptide, substance P, and bombesin bind to the serpin-enzyme complex receptor. , 1991, The Journal of biological chemistry.
[29] M. Pericak-Vance,et al. Segregation of a missense mutation in the amyloid precursor protein gene with familial Alzheimer's disease , 1991, Nature.
[30] P. May,et al. Neurotoxicity of Human Amylin in Rat Primary Hippocampal Cultures: Similarity to Alzheimer's Disease Amyloid‐β Neurotoxicity , 1993, Journal of neurochemistry.
[31] M. Mattson,et al. beta-Amyloid peptides destabilize calcium homeostasis and render human cortical neurons vulnerable to excitotoxicity , 1992, The Journal of neuroscience : the official journal of the Society for Neuroscience.
[32] S. Udenfriend,et al. Fluorometric assay of proteins in the nanogram range. , 1973, Archives of biochemistry and biophysics.
[33] H. Mantsch,et al. Human and rodent Alzheimer beta-amyloid peptides acquire distinct conformations in membrane-mimicking solvents. , 1993, European journal of biochemistry.
[34] C. Cotman,et al. Aggregation-related toxicity of synthetic beta-amyloid protein in hippocampal cultures. , 1991, European journal of pharmacology.
[35] P. Fraser,et al. pH-dependent structural transitions of Alzheimer amyloid peptides. , 1991, Biophysical journal.
[36] Bruce A. Yankner,et al. Methodological variables in the assessment of beta amyloid neurotoxicity , 1992, Neurobiology of Aging.
[37] G H Sato,et al. Growth of a rat neuroblastoma cell line in serum-free supplemented medium. , 1979, Proceedings of the National Academy of Sciences of the United States of America.
[38] B. Ghetti,et al. A mutation in the amyloid precursor protein associated with hereditary Alzheimer's disease. , 1991, Science.
[39] B. Frangione,et al. Ten to fourteen residue peptides of Alzheimer's disease protein are sufficient for amyloid fibril formation and its characteristic x-ray diffraction pattern. , 1987, Biochemical and biophysical research communications.
[40] G. Forloni,et al. Apoptosis mediated neurotoxicity induced by chronic application of beta amyloid fragment 25-35. , 1993, Neuroreport.
[41] J. Reed,et al. Aggregation and secondary structure of synthetic amyloid βA4 peptides of Alzheimer's disease , 1991 .